Cardinal Health, Inc. (CAH)
- Previous Close
112.20 - Open
112.23 - Bid 92.00 x 1100
- Ask 113.16 x 900
- Day's Range
111.88 - 113.13 - 52 Week Range
85.82 - 116.04 - Volume
1,836,612 - Avg. Volume
1,938,519 - Market Cap (intraday)
27.486B - Beta (5Y Monthly) 0.62
- PE Ratio (TTM)
32.67 - EPS (TTM)
3.45 - Earnings Date Nov 1, 2024 - Nov 5, 2024
- Forward Dividend & Yield 2.02 (1.79%)
- Ex-Dividend Date Oct 1, 2024
- 1y Target Est
117.08
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
www.cardinalhealth.comRecent News: CAH
View MoreResearch Reports: CAH
View MorePerformance Overview: CAH
Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CAH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CAH
View MoreValuation Measures
Market Cap
27.49B
Enterprise Value
27.45B
Trailing P/E
32.67
Forward P/E
14.88
PEG Ratio (5yr expected)
0.97
Price/Sales (ttm)
0.12
Price/Book (mrq)
--
Enterprise Value/Revenue
0.12
Enterprise Value/EBITDA
13.99
Financial Highlights
Profitability and Income Statement
Profit Margin
0.38%
Return on Assets (ttm)
3.03%
Return on Equity (ttm)
--
Revenue (ttm)
226.83B
Net Income Avi to Common (ttm)
852M
Diluted EPS (ttm)
3.45
Balance Sheet and Cash Flow
Total Cash (mrq)
5.33B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
3.96B